Hot-spot mutations in hepatitis B virus core gene: Eliciting or evading immune clearance?

Journal of Viral Hepatitis

Volumn 12, Issue 2, 2005, Pages 146-153

  Liu, Z ^a   Luo, Kangxian ^a   He, H ^a   Hou, J ^a  

^a FIRST MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Hepatitis B virus; Immune response; Mutation; Recombinant adenovirus

Indexed keywords

ADENOVIRUS VECTOR; HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIGEN; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; THYMIDINE; TRITIUM; VIRUS DNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL STRAIN HEPG2; CELLULAR IMMUNITY; CHEMOLUMINESCENCE; CONTROLLED STUDY; DNA SEQUENCE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE MUTATION; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNOGENICITY; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN; T LYMPHOCYTE; VIRUS CORE; VIRUS GENE; VIRUS GENOME; VIRUS RECOMBINANT;

ANIMALS; ANTIBODY FORMATION; BASE SEQUENCE; CELLS, CULTURED; DISEASE MODELS, ANIMAL; DNA, VIRAL; FEMALE; HEPATITIS B; HEPATITIS B CORE ANTIGENS; HEPATITIS B VIRUS; IMMUNITY, CELLULAR; MALE; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; MUTATION; PROBABILITY; RECOMBINANT FUSION PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; VIRAL CORE PROTEINS;

EID: 14844292589     PISSN: 13520504     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2005.00552.x     Document Type: Article

References (32)

1. Banatvala JE, Damme P. Hepatitis B vaccine-do we need boosters? J Viral Hepat 2003; 10: 1-6.
2. Chisari FV, Ferrari C. Hepatitis B virus immunopathogenesis. Ann Rev Immunol 1995; 13: 29-60.
3. Naoumov NV, Eddleston ALWF. Host immune response and variations in the virus genome: pathogenesis of liver damage caused by hepatitis B virus. Gut 1994; 35: 1013-1017.
4. Brunetto MR, Stemler M, Schodel F et al. Identification of HBV variants which cannot produce precore derived HBeAg and may be responsible for severe hepatitis. Ital J Gastroenterol Hepatol 1989; 21: 151-154.
5. Carman WF, Jacyna MR, Hadziyannis S et al. Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection. Lancet 1989; 2: 588-591.
6. Li J, Buckwold VE, Hon MW, Ou JH. Mechanism of suppression of hepatitis B virus precore RNA transcription by a frequent double mutation. J Virol 1999; 73: 1239-1244.
7. Buckwold VE, Xu Z, Chen M, Yen TSB, Ou JH. Effect of a naturally occurring mutation in the hepatitis B virus basal core promoter on precore gene expression and viral replication. J Virol 1996; 70: 5845-5851.
8. Ehata T, Omata M, Yokosuka O, Hosoda K, Ohto M. Variations in codons 84-101 in the core nucleotide sequence correlate with hepatocellular injury in chronic hepatitis B virus infection. J Clin Invest 1992; 89: 332-338.
9. Ehata T, Omata M, Chuang WL et al. Mutations in core nucleotide sequence of hepatitis B virus correlate with fulminant and severe hepatitis. J Clin Invest 1993; 91: 1206-1213.
10. Akarca US, Lok ASF. Naturally occurring hepatitis B virus core gene mutations. Hepatology 1995; 22: 50-60.
11. Chuang WL, Omata M, Ehata T et al. Precore mutations and core clustering mutations in chronic hepatitis B virus infection. Gastroenterology 1993; 104: 263-271.
12. Luo KX, Yang J, Liang CS, Zhang L. Correlation between HBV preC/C gene mutations and advanced pathologic activity in chronic hepatitis B. Chin J Inter Med 1994; 33: 763-766.
13. Sprinzl MF, Oberwinkler H, Schaller H, Protzer U. Transfer of hepatitis B virus genome by adenovirus vectors into cultured cells and mice: crossing the species barrier. J Virol 2001; 75: 5108-5118.
14. He TC, Zhou S, da Costa LT, Yu J, Kinzler KW, Volgelstein B. A simplified system for generating recombinant adenovirus. Proc Natl Acad Sci USA 1998; 95: 2509-2514.
15. Summers J, Smith PM, Horwich AL. Hepadnavirus envelop proteins regulate covalently closed circular DNA amplification. J Virol 1990; 64: 2819-2824.
16. Gupta RK, Siber GR. Method for quantitation of IgG subclass antibodies in mouse serum by enzyme-linked immunosorbent assay. J Immunol Method 1995; 181: 75-81.
17. Bozkaya H, Ayola B, Lok ASF. High rate of mutations in the hepatitis B core gene during the immune clearance phase of chronic hepatitis B virus infection. Hepatology 1996; 24: 32-37.
18. Yuan TT, Sahu GK, Whitehead WE, Greenberg R, Shih C. The mechanism of an immature secretion phenotype of a highly frequent naturally occurring missense mutation at codon 97 of human hepatitis B virus core antigen. J Virol 1999; 73: 5731-5740.
19. Yuan TT, Shih C. A frequent naturally occurring mutation (P130T) of human hepatitis B virus core antigen is compensatory for immature secretion phenotype of another frequent variant (I97L). J Virol 2000; 74: 4929-4932.
20. Suk FM, Lin MH, Newman M et al. Replication advantage and host factor-independent phenotypes attributable to a common naturally occurring capsid mutation (I97L) in human hepatitis B virus. J Virol 2002; 76: 12069-12077.
21. Pogam SL, Yuan TT, Sahu GK, Chatterjee S, Shih C. Low-level secretion of human hepatitis B virus caused by two independent, naturally occurring mutations (P5T and L60V) in the capsid protein. J Virol 2000; 74: 9099-9105.
22. Xiang ZQ, Yang YP, Wilson JM, Ertl HCJ. A replication-defective human adenovirus recombinant serve as a highly efficacious vaccine carrier. Virology 1996; 219: 220-227.
23. Fooks AR, Schadeck E, Liebert UG et al. High level expression of the measles virus nucleocapsid protein by using a replication-deficient adenovirus vector: induction of an MHC-1-restricted CTL response and protection in a murine model. Virology 1995; 210: 456-465.
24. Milich DR, McLachlan A, Stahl S et al. Comparative immunogenicity of hepatitis B virus core and E antigens. J Immunol 1988; 141: 3617-3624.
25. Schodel F, Peterson D, Milich D. Hepatitis B virus core and e antigen: immune recognition and use as a vaccine carrier moiety. Intervirology 1996; 39: 104-110.
26. Mosmann TR, Coffman RL. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989; 7: 145-173.
27. Finkelman FD, Holmes J, Katona M et al. Lymphokine control of in vivo immunogloblin isotype selection. Annu Rev Immunol 1990; 8: 303-333.
28. Jung M, Spengler U, Schraut W et al. Hepatitis B virus antigen-specific T-cell activation in patients with acute and chronic hepatitis B. J Hepatol 1991; 13: 310-317.
29. Wakita T, Kakumu S, Yoshioka K, Ishikawa T, Ito Y, Shinagawa T. Cellular immune responses of peripheral blood mononuclear cells to HBV antigens during chronic and acute HBV infection. Digestion 1992; 52: 26-33.
30. Lohr HF, Weber W, Schlaak JF et al. Proliferative response of CD4+ T cells and HBV clearance in chronic hepatitis B with and without HBe-minus HBV mutants. Hepatology 1995; 22: 61-68.
31. Evavold BD, Sloan-Lancaster J, Allen PM. Tickling the TCR: selective T-cell functions stimulated by altered peptide ligands. Immunol Today 1993; 14: 602-609.
32. Carman WF, Boner W, Fattovich G et al. Hepatitis B virus core protein mutations are concentrated in B cell epitopes in progressive disease and in T helper cell epitopes during clinical remission. J Infect Dis 1997; 175: 1093-1100.